Drug Law Weekly

Children's Hospital of Pittsburgh - Symptomatic cerebrovascular accidents are rare following the Fontan procedure

Children's Hospital, Philadelphia - Therapy and dosing for pediatric rheumatic disorders reviewed

Chocolate Manufacturers Association - Amounts of antioxidants, flavanols in chocolate, cocoa powder vary, study shows

Chromocell Corporation - High-dose leptin treatment results in leptin resistance

Cleveland BioLabs - Biotech company completes $5.9M financing round

Cognis Nutrition & Health - Study shows effectiveness of conjugated linoleic acid supplement in weight loss

Columbia Laboratories, Inc. - Abstract on lidocaine vaginal gel published

Corautus Genetics, Inc. - Phase IIb GENASIS clinical trial receives recommendation to proceed

Critical Therapeutics, Inc. - Supplemental new drug application submitted to FDA for ZYFLO

Curis, Inc. - Candidate for basal cell carcinoma under co-development by Genentech, partner

Cyberkinetics Neurotechnology Systems - Company gives update on BrainGate clinical trial

Dade Behring, Inc. - Company reports on recall of MicroScan Rapid Pos inoculum broth

Dana Farber Cancer Institute, Boston - Researchers provide details of new studies and findings in the area of oncology

Daniel den Hoed Cancer Center - "Pain pen" shows promise for treatment of breakthrough cancer pain

Discovery Partners International, Inc. - Michael C. Venuti, PhD, named of chief scientific officer

Dr. Reddy's Laboratories - Company announces $56M partnership for commercialization of ANDAs

E. China University of Science & Technology - Optimization of carbon source for cordycepin production evaluated

EMO Centro Cuore Columbus - Single- and double-branch sirolimus-eluting stent treatment has similar outcome

EPS Charles Nicolle, Tunis - Percutaneous treatment of gas-containing epidural pseudocyst reported

Eisai Inc. - Zonisamide capsules don't affect pharmacokinetics of OCs containing EE, NOR

Eli Lilly & Co. - Schizophrenics on atypical antipsychotic treated longer than with typical drugs

Erasmus Medical Center-Sophia Rotterdam - Research add new data to pneumococcal vaccines body of knowledge

Evans Biomedical Research Center - Lithium promotes cell survival in the absence of soluble survival factors

Exeter Life Sciences, Inc. - Geron enters joint venture for licensing animal-cloning technologies

Experimental Biology - New study documents the detrimental impact of teen beverage choices

Hovione FarmaCiencia SA - Portugal-based company successful in drug development

Lumetra - Medicare Web resource gives quality of care information

Millennium Pharmaceuticals, Inc. - FDA grants full approval for VELCADE (bortezomib) for injection

Montefiore Medical Center - Heart surgeon appointed chair of cardiothoracic surgery at Montefiore Medical

Ranbaxy Pharmaceuticals Inc. - Pharma company receives FDA approval to market a generic alternative to Macrobid

Sucampo Pharmaceuticals - NDA for investigational compound to treat chronic constipation submitted

U.S. Food & Drug Administration - Challenges in tuberculosis vaccine development reviewed

U.S. Food & Drug Administration - Isotretinoin levels after single oral dose determined by HPLC

U.S. Food & Drug Administration - Mechanism of guanine nucleotide exchange of Ras GTPase outlined

U.S. Food & Drug Administration - Rat-based neurovirulence test for mumps virus assessed

Ziopharm, Inc. - U.S.FDA grants approval of IND for clinical trial of organic arsenic compound

sanofi-aventis - Influenza-focused drug company awarded $97 million U.S. HHS vaccine contract